Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206277) titled 'Fibroscan to Guide Post Transplant Immunosuppression Minimization' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Alberta

Condition: Immunosuppression

Intervention: Other: Immunosuppression reduction

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 1, 2025

Target Sample Size: 50

To know more, visit https://clinicaltrials.gov/study/NCT07206277

Published by HT Digital Content Services with permission from Health...